EyePoint Pharmaceuticals(DE:PV3B)
€0.25-0.03 (-9.35%)
DE:PV3B
EyePoint Pharmaceuticals earnings date
€0.25
At close:-0.03 (-9.35%)
EyePoint Pharmaceuticals (PV3B) Q2 2026 Earnings Report
1 Followers
DE:PV3B Q2 2026 EPS Results
- Actual EPS
- -EUR 0.99
- Consensus EPS
- -EUR 0.90
- Beat/Miss
- Missed by -EUR 0.10
- One Year Ago EPS
- -EUR 0.77
DE:PV3B Q2 2026 Revenue Results
- Actual Revenue
- EUR 462.17K
- Expected Revenue
- EUR 403.83K
- Beat/Miss
- Beat by +EUR 58.34K
- YoY Revenue Growth
- -90.49%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/05/2026
- Time
- Before Open
- Conference Call
- Wednesday, August 5, 2026
DE:PV3B Upcoming Earnings
EyePoint Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:PV3B Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.63- | -0.74 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.85-0.98 | -0.77 | -25.88% (-0.20) | |
| Aug 05, 2026 | 2026 (Q2) | -0.90-0.99 | -0.77 | -28.24% (-0.22) | |
| May 06, 2026 | 2026 (Q1) | -0.73-0.90 | -0.59 | -52.31% (-0.31) | |
| Mar 04, 2026 | 2025 (Q4) | -0.68-0.74 | -0.58 | -26.56% (-0.15) | |
| Nov 05, 2025 | 2025 (Q3) | -0.70-0.77 | -0.49 | -57.41% (-0.28) | |
| Aug 06, 2025 | 2025 (Q2) | -0.75-0.77 | -0.53 | -46.55% (-0.25) | |
| May 07, 2025 | 2025 (Q1) | -0.61-0.59 | -0.5 | -18.18% (-0.09) | |
| Mar 05, 2025 | 2024 (Q4) | -0.44-0.58 | -0.3 | -93.94% (-0.28) | |
| Nov 07, 2024 | 2024 (Q3) | -0.50-0.49 | -0.3 | -63.64% (-0.19) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

